One-Trick Pony Boan Biotech Files for Hong Kong IPO Into Tough Market

The biotech company is awaiting approval on a second drug to drive up revenue as it firms its foothold in a competitive landscape Key Takeaways: Boan Biotechnology sells only one product so far and is facing stiff competition from other similar drugs Luye Pharma bought Boan in 2020 and is taking it public at a time when markets are bearish By Molly Wen Shandong Boan Biotechnology Co. Ltd. recently filed for an IPOon the Hong Kong Stock Exchange to raise cash to boost drug development, marketing and research. Hong Kong-listed…

Read More »

FAST NEWS: Cloopen Warned After Missing Filing Deadline

The latest: Cloud-based services provider Cloopen Group Holding Ltd. (RAAS.US) said last Friday it was informed by the New York Stock Exchange (NYSE) on May 18 that it failed to file its annual report for the year ended Dec. 31 before the required deadline, putting it out of compliance with listing rules. Looking up: The notification has no immediate effect on the company’s listing status, except that an “LF” indicator will be attached to its “RAAS” trading symbol to indicate its status as a late filer until it regains compliance with the…

Read More »

After Rising to Fame as Hot Audio Social App, Yalla Finds New Role Model in Facebook

Emerging markets-focused social media company details several new initiatives in its latest quarterly report as it diversifies beyond its core voice-based services Key Takeaways: Yalla said its first-quarter revenue rose 6.9% to a record $72.3 million, as strong gains for its game services offset a first-time decline for its core voice business Company is launching a wide array of new initiatives, including an instant messaging app and its first-ever hardcore game, in a bid to become more diversified By Doug Young It burst onto investor radar screens with comparisons to…

Read More »